AdaptVac Information

View Top Employees from AdaptVac

AdaptVac is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of the Joint Venture is to create a world class unit for the development of highly competitive vaccines and therapeutics against infectious diseases, cancer, and immunological disorders. The combination of ExpreS2ion’s proprietary insect cell expression technology, ExpreS2, and NextGen’s unique expertise in proprietary Virus-Like Particle (VLP) technology makes us a strong and versatile player in the field of new vaccines and immune therapy.

Website	http://www.adaptvac.com
Employees	9 (5 on RocketReach)
Founded	2017
Phone	+45 26 39 46 49
Technologies	JavaScript , HTML , Twitter +8 more (view full list)
Industry	Biotechnology Research
Keywords	Vaccine Research, Vaccine Development, Vaccine Technology, Next Generation Vaccines, Viral Vector Vaccines, Biotechnology, Rna Vaccines, Immunotherapy, Immunology, Biopharma, Cancer Vaccines, Dna Vaccines, Pharmaceutical Research, Therapeutics, Drug Development, Clinical Trials, Vaccine Manufacturing, Drug Discovery
Competitors	Johnson & Johnson, Medtronic, Stryker, Boston Scientific, Zimmer Biomet, Smith+Nephew, B. Braun Group, Olympus Corporation, CR Bard - Europe, Middle East and Africa (EMEA) +33 more (view full list)